DNA methylation levels are associated with CRF(1) receptor antagonist treatment outcome in women with post-traumatic stress disorder

BACKGROUND: We have previously evaluated the efficacy of the CRF(1) receptor antagonist GSK561679 in female PTSD patients. While GSK561679 was not superior to placebo overall, it was associated with a significantly stronger symptom reduction in a subset of patients with probable CRF system hyperacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Pape, Julius C., Carrillo-Roa, Tania, Rothbaum, Barbara O., Nemeroff, Charles B., Czamara, Darina, Zannas, Anthony S., Iosifescu, Dan, Mathew, Sanjay J., Neylan, Thomas C., Mayberg, Helen S., Dunlop, Boadie W., Binder, Elisabeth B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215613/
https://www.ncbi.nlm.nih.gov/pubmed/30390684
http://dx.doi.org/10.1186/s13148-018-0569-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215613/
https://www.ncbi.nlm.nih.gov/pubmed/30390684
http://dx.doi.org/10.1186/s13148-018-0569-x

Ejemplares similares